Literature DB >> 23698067

Potential hazard drug-drug interaction between boosted protease inhibitors and vinblastine in HIV patients with Hodgkin's lymphoma.

Giuseppe Corona, Emanuela Vaccher, Michele Spina, Giuseppe Toffoli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698067     DOI: 10.1097/QAD.0b013e32835e0777

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

Review 1.  Cancer clinical trials in persons with HIV infection.

Authors:  Richard F Little
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

Review 2.  How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Authors:  Thomas S Uldrick; Richard F Little
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 3.  The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Authors:  Emanuela Vaccher; Diego Serraino; Antonino Carbone; Paolo De Paoli
Journal:  Oncologist       Date:  2014-06-26

4.  Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

Authors:  Antonella Cingolani; Alessandro Cozzi Lepri; Luciana Teofili; Laura Galli; Valentina Mazzotta; Gian Maria Baldin; Stefan Hohaus; Alessandra Bandera; Lucia Alba; Nadia Galizzi; Antonella Castagna; Antonella D'arminio Monforte; Andrea Antinori
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

5.  Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma: a retrospective analysis.

Authors:  F Sombogaard; E J F Franssen; W E Terpstra; E D Kerver; G E L van den Berk; M Crul
Journal:  Int J Clin Pharm       Date:  2018-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.